National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

meropenem
A broad-spectrum carbapenem with antibacterial properties, synthetic Meropenem inhibits cell wall synthesis in gram-positive and gram-negative bacteria. It penetrates cell walls and binds to penicillin-binding protein targets. Meropenem acts against aerobes and anaerobes including Klebsiella, E. coli, Enterococcus, Clostridium sp.. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Meropenem Trihydrate
US brand name:Merrem I.V.
Code names:SM-7338
SM-7338



Previous:Menogarol, meperidine hydrochloride, Meprolone, mercaptopurine, Mercaptopurinum
Next:Merrem I.V., mesna, Mesnex, mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine, MET receptor tyrosine kinase inhibitor SGX523

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov